Bioneer Corp 064550
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 29,350.00–30,750.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 30,100.00 / KRW 30,200.00
- Market Cap
- KRW 776.89 Bil
- Volume/Avg
- 175,929 / 399,817
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.93
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bioneer Corp engages in the manufacture and sale of biotechnological products in South Korea. It offers deoxyribonucleic acid (DNA) reagents, molecular diagnostic kits, DNA and ribonucleic acid (RNA) amplification products, human diagnostics kits, veterinary diagnostics kits, among others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 594
- Website
- http://www.bioneer.co.kr
Comparables
Valuation
|
Metric
|
064550
|
377740
|
084650
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 18.09 | — |
Price/Book Value | 3.45 | 0.27 | 0.89 |
Price/Sales | 2.93 | 4.64 | 2.77 |
Price/Cash Flow | 107.59 | — | 167.49 |
Price/Earnings
064550
377740
084650
Financial Strength
|
Metric
|
064550
|
377740
|
084650
|
|---|---|---|---|
Quick Ratio | 1.94 | 39.35 | 2.38 |
Current Ratio | 2.75 | 42.26 | 2.47 |
Interest Coverage | 0.03 | −221.49 | −1.33 |
Quick Ratio
064550
377740
084650
Profitability
|
Metric
|
064550
|
377740
|
084650
|
|---|---|---|---|
Return on Assets (Normalized) | −1.85% | 1.38% | 1.86% |
Return on Equity (Normalized) | −2.46% | 1.49% | 2.42% |
Return on Invested Capital (Normalized) | −2.05% | 0.31% | 2.00% |
Return on Assets
064550
377740
084650
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qztmmtftzc | Rpmy | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Gptykgmcs | Kcvsk | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Vcqvrtnj | Sgcqjyg | $99.5 Bil | |
MRNA
| Moderna Inc | Snkmyysj | Sqbs | $38.8 Bil | |
ARGX
| argenx SE ADR | Ynrlhmq | Hhtbs | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Gynylyw | Sntt | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Ytvhkch | Cwqtvnn | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Dzyythh | Gsjgws | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Cvncydzxzm | Lhgbcw | $12.5 Bil | |
INCY
| Incyte Corp | Nkgkdmvy | Pbyhrch | $11.6 Bil |